Latest "Stella Technology, Inc." News Stories - Page: 5

13:05 EDT 20th August 2018 | BioPortfolio

Here are the most relevant search results for "Stella Technology, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Stella Technology, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Stella Technology, Inc. for you to read. Along with our medical data and news we also list Stella Technology, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Stella Technology, Inc. Companies for you to search.

Showing "Stella Technology" News Articles 101–125 of 12,000+

Friday 17th August 2018

Tumour Trace device 'just makes sense' - Lancor's chief medical officer

Lancor Scientific's chief operating officer Gopal Rao and chief medical officer Roland Schlesinger discuss with Proactive Investors some of the upcoming milestones for their Tumour Trace technology. Roland Schlesinger's a specialist in health technology assessment - essentially analysing pharmaceuticals or medical technologies for efficiency and efficacy. ''The great thing about the technolo...

Circulating Tumor Cells Get "Sucked Up" By Malaria Protein

Scientists in Copenhagen have developed a new tool for diagnosing and monitoring a wide variety of cancers, which uses a malaria protein known rVAR2 to grab hold of and remove circulating tumor cells (CTCs) from blood samples. The researchers, headed by Mette Ø. Agerbæk, Ph.D., and Ali Salanti, Ph.D., at the University of Copenhagen’s department of immunology and microbiology, foun...

So you want to break into the Chinese vaccine market?

Last week, one of China’s largest vaccine makers, Changchun Changsheng Biotechnology, was exposed for selling and distributing hundreds of thousands...Read More... The post So you want to break into the Chinese vaccine market? appeared first on Pharmaceutical Technology.

After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics

On July 24, Nabriva Therapeutics announced the acquisition of Zavante Therapeutics, a biotechnology company developing treatments for the infections that...Read More... The post After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics appeared first on Pharmaceutical Technology.

Revlimid demonstrates positive phase III results in Indolent NHL

Celgene has announced positive new data for its leading blockbuster drug, Revlimid (lenalidomide), which earned revenues of $8.2bn in 2017....Read More... The post Revlimid demonstrates positive phase III results in Indolent NHL appeared first on Pharmaceutical Technology.

UK's NICE In The Dock Again After 'No' For Biogen SMA Drug

Following draft guidance that looks likely to reject Spinraza, the US biotech believes that UK health technology body NICE is...

Valeritas Inc Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryValeritas Inc Valeritas is a medical technology company that develops and commercializes treatment solutions for diabetes. The company's product includes VGo insulin delivery device a wearable basalbolus insulin delivery solution for patients with Type 2 diabetes. It also provides VGo link device connectivity, hPatch fully disposable, VGo prefill device, controlled delivery technology platf...

Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins

Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at Unit DX science incubator in Bristol, UK. Ziylo has been pioneering the use of its platform technology - synthetic glucose binding molecules - for therapeutic and diagnostic applications.

FDA Approves Sun Pharma's Dry Eye Treatment

NewsCequa is the first and only dry eye treatment to combine cyclosporine A with nanomicellar technology.Contributed Author: 

Callitas Health ropes in BFS Innovations and Pure Leaf Group to launch CannaStrips globally

The Cincinnati-based company has developed a novel delivery technology that helps achieve more precise dosing — a tricky undertaking when it comes to medical cannabis

FDA Grants 510(k) Clearance to New Spinal Implant

The Foundation 3D anterior lumbar interbody cage implant uses CoreLink's proprietary mimetic metal technology, which mimics key characteristics of natural bone. FDA Approvals

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical tria...

GEA receives green light for aseptic blow-fill-cap technology

The US Food and Drug Administration has awarded the engineering company a letter of no objection for its integrated filling and capping solution featuring a fully aseptic rotary blowing machine

Umicore Licenses Cross-Coupling Catalysts from MIT

The business unit Precious Metals Chemistry of Umicore is expanding its existing cross-coupling catalyst portfolio with Buchwald precatalysts that the Belgian materials technology group licensed from the Massachusetts Institute of Technology (MIT).

ISG Expands Provider Evaluations to the UK

LONDON, Aug. 17, 2018 /PRNewswire/ -- Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, today announced it is expanding Read more...

Right of Reply Nominates David Orban's Network Society as Technical Advisor

LONDON, August 17, 2018 /PRNewswire/ -- Right of Reply ("RoR"), a fast-growing technology company dedicated to protecting the reputations of people and institutions on the Read more...

King Abdullah University of Science and Technology (KAUST) Chooses Heliospectra for New Speed ...

GOTHENBURG, Sweden and SAN FRANCISCO, Aug. 17, 2018 /PRNewswire/ -- Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for Read more...

Detecting hundreds of proteins in a single sample

New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike. Proteins found in blood provide scientists and clinicians with key information on our...

Infectious Disease Diagnostics Market by Product Service Assay, Kit Reagent, Instruments, Disease Type Hepatitis, HIV, HAI, HPV, TB, Influenza, Technology Immunodiagnostics, PCR, NGS, End User Hospital, Research Institute Global Forecast to 2022 [Repor

The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%.The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratorie...

Stryker Corp SYK Product Pipeline Analysis, 2018 Update [Report Updated: 15052018] Prices from USD $750

SummaryStryker Corp Stryker is a medical technology company that manufactures medical equipment. The company offers orthopaedic, medical and surgical, and neurotechnology and spine products and provides services. Its major products include orthopaedic implants; surgical equipment and surgical navigation systems; patient handling, emergency medical equipment and intensive care disposable products; ...

New CRISPR technology may help eliminate mutated gene sequence

In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell's internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building.

New Manufacturing Technique Could Improve Common Problem in Printing Technology

A new manufacturing technique developed by researchers from Binghamton University, State University at New York may be able to avoid the "coffee ring" effect that plagues inkjet printers

Thursday 16th August 2018

Verax Biomedical Inc Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryVerax Biomedical Inc Verax is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company's products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD technology to conduct its tests. Verax's product platelet pgd test is used for the detection of bacterial c...

People Counting System Market by Technology IR Beam, VideoBased, Thermal Imaging, Hardware and Software, End User Retail Stores, Supermarkets, and Shopping Malls, Transportation, Corporate, Hospitality, and Region Global Forecast to 2023 [Report Updated:

People counting system market is projected to grow at a CAGR of 10.6% between 2018 and 2023The people counting system market is in the growth phase and is estimated to be valued at USD 694.7 million in 2018. The market is expected to be worth USD 1,150.2 million by 2023, growing at a CAGR of 10.6% between 2018 and 2023. The drivers for this market include the growing retail sector and increased ad...

Shanghai ChemPartner Announces Merger Deal Closure with Quantum

SHANGHAI, Aug. 17, 2018 /PRNewswire/ -- Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development  services, announced the closure of the merger deal with Quantum Hi-Tech China Biological. Quantum, in a press release in 2017, announced their intent to join with Shanghai ChemPartner, a science-drive, technology-b...

Quick Search


News Quicklinks